These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30616938)

  • 41. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
    Orsi GB; Di Stefano L; Noah N
    Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid cycle development of a multifactorial intervention achieved sustained reductions in central line-associated bloodstream infections in haematology oncology units at a children's hospital: a time series analysis.
    Dandoy CE; Hausfeld J; Flesch L; Hawkins D; Demmel K; Best D; Osterkamp E; Bracke T; Nagarajan R; Jodele S; Holt J; Giaccone MJ; Davies SM; Kotagal U; Simmons J
    BMJ Qual Saf; 2016 Aug; 25(8):633-43. PubMed ID: 26608456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implementation of central venous catheter bundle in an intensive care unit in Kuwait: Effect on central line-associated bloodstream infections.
    Salama MF; Jamal W; Al Mousa H; Rotimi V
    J Infect Public Health; 2016; 9(1):34-41. PubMed ID: 26138518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hospital-acquired Staphylococcus aureus primary bloodstream infection: A comparison of events that do and do not meet the central line-associated bloodstream infection definition.
    Kovacs CS; Fatica C; Butler R; Gordon SM; Fraser TG
    Am J Infect Control; 2016 Nov; 44(11):1252-1255. PubMed ID: 27158091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central line maintenance bundles and CLABSIs in ambulatory oncology patients.
    Rinke ML; Bundy DG; Chen AR; Milstone AM; Colantuoni E; Pehar M; Herpst C; Fratino L; Miller MR
    Pediatrics; 2013 Nov; 132(5):e1403-12. PubMed ID: 24101764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Prospective, Holistic, Multicenter Approach to Tracking and Understanding Bloodstream Infections in Pediatric Hematology-Oncology Patients.
    Gaur AH; Bundy DG; Werner EJ; Hord JD; Miller MR; Tang L; Lawlor JP; Billett AL;
    Infect Control Hosp Epidemiol; 2017 Jun; 38(6):690-696. PubMed ID: 28399945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pediatric Ambulatory Central Line-Associated Bloodstream Infections.
    Rinke ML; Heo M; Saiman L; Bundy DG; Rosenberg RE; DeLaMora P; Rabin B; Zachariah P; Mirhaji P; Ford WJH; Obaro-Best O; Drasher M; Klein E; Peshansky A; Oyeku SO
    Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33386333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central line-associated bloodstream infections in limited-resource countries: a review of the literature.
    Rosenthal VD
    Clin Infect Dis; 2009 Dec; 49(12):1899-907. PubMed ID: 19911941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of infection control cost reimbursement policy on central line-associated bloodstream infections.
    Park JY; Kwon KT; Lee WK; Kim HI; Kim MJ; Song DY; Yu MH; Park HJ; Lee KH; Chae HJ
    Am J Infect Control; 2020 May; 48(5):560-565. PubMed ID: 31677923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of chlorhexidine baths on central-line-associated bloodstream infections in a neonatal intensive care unit in a developing country.
    Cleves D; Pino J; Patiño JA; Rosso F; Vélez JD; Pérez P
    J Hosp Infect; 2018 Nov; 100(3):e196-e199. PubMed ID: 29588187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating the impact of mandatory public reporting on participation and performance in a program to reduce central line-associated bloodstream infections: evidence from a national patient safety collaborative.
    Marsteller JA; Hsu YJ; Weeks K
    Am J Infect Control; 2014 Oct; 42(10 Suppl):S209-15. PubMed ID: 25239712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utilizing a line maintenance team to reduce central-line-associated bloodstream infections in a neonatal intensive care unit.
    Holzmann-Pazgal G; Kubanda A; Davis K; Khan AM; Brumley K; Denson SE
    J Perinatol; 2012 Apr; 32(4):281-6. PubMed ID: 22011970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multicenter study in Colombia: Impact of a multidimensional International Nosocomial Infection Control Consortium (INICC) approach on central line-associated bloodstream infection rates.
    Álvarez-Moreno CA; Valderrama-Beltrán SL; Rosenthal VD; Mojica-Carreño BE; Valderrama-Márquez IA; Matta-Cortés L; Gualtero-Trujillo SM; Rodríguez-Peña J; Linares-Miranda CJ; Gonzalez-Rubio ÁP; Vega-Galvis MC; Riaño-Forero I; Ariza-Ayala BE; García-Laverde G; Susmann O; Mancera-Páez O; Olarte N; Rendón-Campo LF; Astudillo Y; Trullo-Escobar MD; Orellano PW
    Am J Infect Control; 2016 Nov; 44(11):e235-e241. PubMed ID: 27317408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countries.
    Rosenthal VD; Maki DG; Rodrigues C; Alvarez-Moreno C; Leblebicioglu H; Sobreyra-Oropeza M; Berba R; Madani N; Medeiros EA; Cuéllar LE; Mitrev Z; Dueñas L; Guanche-Garcell H; Mapp T; Kanj SS; Fernández-Hidalgo R;
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1264-72. PubMed ID: 21029008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical impact and cost-effectiveness of a central line bundle including split-septum and single-use prefilled flushing devices on central line-associated bloodstream infection rates in a pediatric intensive care unit.
    Devrim İ; Yaşar N; İşgüder R; Ceylan G; Bayram N; Özdamar N; Turgut N; Oruç Y; Gülfidan G; Ağırbaş İ; Ağın H
    Am J Infect Control; 2016 Aug; 44(8):e125-8. PubMed ID: 27061256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report.
    Rogers AE; Eisenman KM; Dolan SA; Belderson KM; Zauche JR; Tong S; Gralla J; Hilden JM; Wang M; Maloney KW; Dominguez SR
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27616655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings.
    Tedja R; Gordon SM; Fatica C; Fraser TG
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):164-8. PubMed ID: 24442079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of central-line-associated bloodstream infections and catheter-related bloodstream infections: a systematic review and meta-analysis.
    Elangovan S; Lo JJ; Xie Y; Mitchell B; Graves N; Cai Y
    J Hosp Infect; 2024 Aug; 152():126-137. PubMed ID: 39151801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiology of central line-associated bloodstream infections in Quebec intensive care units: a 6-year review.
    Fontela PS; Platt RW; Rocher I; Frenette C; Moore D; Fortin E; Buckeridge D; Pai M; Quach C
    Am J Infect Control; 2012 Apr; 40(3):221-6. PubMed ID: 21824682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central-line-associated bloodstream infections in a pediatric oncology and hematology hospital at home program.
    Raimbault SC; Domenech C; Fuhrmann C; Bertrand A
    Infect Control Hosp Epidemiol; 2023 May; 44(5):780-785. PubMed ID: 35912672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.